dr berg semaglutide Frontiers Beyond weight loss: Integrating GLP-1

Most peptide protocols involve subcutaneous injection, which is a small, shallow injection into the fatty tissue just under the skin (similar to how insulin is administered)

Optimized parameters were obtained by the product ion scan mode of the individual analyte at 10 uM

However, these studies are observational, not randomized trials, so we cannot yet interpret the findings as proof of a cancer risk reduction. The review also addressed the question of whether GLP-1s reduce cancer risk because they cause weight loss and improved metabolism, or because they have a direct anti-cancer effect

These conditions may influence whether GLP-1/GIP agonists are appropriate for you

doi:10.1111/jocd.12910